[Federal Register Volume 64, Number 179 (Thursday, September 16, 1999)]
[Notices]
[Pages 50293-50294]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-24136]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 50294]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Clinical Trials Review Committee.
Date: October 24-25, 1999.
Time: 6:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Joyce A. Hunter, PhD., NHLBI/DEA/Review Branch,
Rockledge Building II, Room 7192, MSC 7924, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 435-0287.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 9, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-24136 Filed 9-15-99; 8:45 am]
BILLING CODE 4140-01-M
